RxDoctor Payments Data

Shirvinda Wijesekera, MD

Orthopaedic Surgery of the Spine · Hamden, CTNPI 1073519583

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $141,085 of the $167,627 with a category attached, or 84.2%. Medical Device Business Services, Inc. accounts for 73.7% of it on its own, with 17 other manufacturers making up the rest.

$167,627in general payments, 2019–2025

Across 468 payments — averaging $358.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$124K
  • Depuy Synthes Products, Inc.$18K
  • Expanding Innovations, Inc.$9K
  • Johnson & Johnson$7K
  • Alphatec Spine, Inc$6K
  • 4web, Inc.$2K
  • plus $3K from 12 others
$9,147in ownership & investment interests, 2019–2025

Across 2 payments — averaging $4573.40 each. An ownership or investment interest held by the physician or an immediate family member.

  • Expanding Innovations, Inc.$9K

What the payments were for

  • Consulting fees$141,08584%
  • Travel & lodging$14,6749%
  • Food & beverage$11,8687%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$167,627 in reported general payments places this provider in the 85th percentile of 25 orthopaedic surgery of the spine providers in Connecticut.

See all orthopaedic surgery of the spine providers in Connecticut

Medicare billing

Part B allowed, 2024
$299,317
Medicare patients
433
Services billed
1,523

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin270$3,947
Methylprednisolone79$559
Nabumetone49$497
Amitriptyline Hcl43$448
Celecoxib18$428
Tizanidine Hcl101$342
Ibuprofen27$252
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen28$187
Amoxicillin-Clavulanate Pot ErAmoxicillin/Potassium Clav16$181
Cyclobenzaprine Hcl30$157
Meloxicam48$134
Tramadol Hcl20$66
Diazepam21$37
Oxycodone Hcl15$34

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Hamden

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →